Literature DB >> 33707176

Prevalence of heated tobacco product use in Japan: the 2020 JASTIS study.

Satomi Odani1, Takahiro Tabuchi2.   

Abstract

BACKGROUND: Japan is the leading market for heated tobacco products (HTPs). We assessed the latest prevalence of HTP use including novel products (Ploom S, glo sens, and Pulze).
METHODS: Data were obtained from an internet-based, self-reported survey conducted during February-March 2020 with individuals aged 15-74 years in Japan(n=9044). Prevalence of current (past 30-day) HTP use and cigarette smoking was computed. Poison regression analysis was conducted to examine predictors of HTP use among current cigarette smokers (n=1478). All analyses were weighted to account for selection bias in the internet survey using a nationally representative sample of Japanese population.
RESULTS: In 2020, prevalence of current HTP use and cigarette smoking was 10.9% and 25.9% in Japan, respectively. The most commonly used HTP brand was IQOS (5.7%) followed by Ploom TECH/Ploom TECH+ (5.4%) and glo (2.6%). Use of Ploom S, glo sens and Pulze was 1.6%, 0.8% and 0.6%, respectively. Among current cigarette smokers, 34.9% of those who were interested in quitting smoking and 30.5% of those who were not interested in quitting reported concurrent use of HTP, respectively (difference not significant). Cigarette smokers who reported having multiple chronic conditions (aPR=2.31), alcohol consumption (aPR=2.07), and e-cigarette use (aPR=1.88) were more likely to use an HTP compared to those who did not report such characteristics.
CONCLUSIONS: HTP use remained prevalent in Japan. One in three current cigarette smokers used HTPs regardless of whether they were interested inquitting smoking. Continuedsurveillance is important to inform national and global tobaccocontrol strategies. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cessation; non-cigarette tobacco products; surveillance and monitoring

Mesh:

Year:  2021        PMID: 33707176     DOI: 10.1136/tobaccocontrol-2020-056257

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   6.953


  9 in total

Review 1.  Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges.

Authors:  Pamela M Ling; Minji Kim; Catherine O Egbe; Roengrudee Patanavanich; Mariana Pinho; Yogi Hendlin
Journal:  Tob Control       Date:  2022-03       Impact factor: 6.953

2.  IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.

Authors:  Yael Bar-Zeev; Carla J Berg; Amal Khayat; Katelyn F Romm; Chritina N Wysota; Lorien C Abroms; Daniel Elbaz; Hagai Levine
Journal:  Tob Control       Date:  2022-02-09       Impact factor: 6.953

3.  Effects of IQOS health warnings and modified risk claims among young adult cigarette smokers and non-smokers.

Authors:  Darren Mays; Andrea C Johnson; Allison Glasser; Melissa Mercincavage; Andrew A Strasser
Journal:  Tob Control       Date:  2021-10-29       Impact factor: 6.953

4.  Impact of workplace smoke-free policy on secondhand smoke exposure from cigarettes and exposure to secondhand heated tobacco product aerosol during COVID-19 pandemic in Japan: the JACSIS 2020 study.

Authors:  Koichiro Takenobu; Satomi Yoshida; Kota Katanoda; Koji Kawakami; Takahiro Tabuchi
Journal:  BMJ Open       Date:  2022-03-18       Impact factor: 2.692

5.  Smoking cessation behaviors and reasons for use of electronic cigarettes and heated tobacco products among Romanian adults.

Authors:  Sumaira Hussain; Chandrashekhar T Sreeramareddy
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

6.  "Time-based" workplace smoking bans during working hours (including and excluding lunchtime) and combustible cigarette and heated tobacco product use: a cross-sectional analysis of the 2020 JASTIS study.

Authors:  Yuki Miyazaki; Takahiro Tabuchi
Journal:  Prev Med Rep       Date:  2022-07-29

7.  A Survey on the Actual Use of and Reasons for Heated Tobacco Products in Patients with Rheumatoid Arthritis.

Authors:  Hisaaki Isaji; Kiyofumi Yamada
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

8.  Association between Heated Tobacco Product Use during Pregnancy and Fetal Growth in Japan: A Nationwide Web-Based Survey.

Authors:  Yoshihiko Hosokawa; Masayoshi Zaitsu; Sumiyo Okawa; Naho Morisaki; Ai Hori; Yukiko Nishihama; Shoji F Nakayama; Takeo Fujiwara; Hiromi Hamada; Toyomi Satoh; Takahiro Tabuchi
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

9.  Heated tobacco products and circulating high-density lipoprotein cholesterol concentrations.

Authors:  Huan Hu; Tohru Nakagawa; Toru Honda; Shuichiro Yamamoto; Toshiaki Miyamoto; Hiroko Okazaki; Masafumi Eguchi; Taiki Shirasaka; Takeshi Kochi; Isamu Kabe; Aki Tomizawa; Takako Miki; Ami Fukunaga; Shohei Yamamoto; Yosuke Inoue; Maki Konishi; Haruka Miyake; Seitaro Dohi; Tetsuya Mizoue
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.